1. The rate of incidental atypical and malignant breast lesions in reduction mammoplasty specimens
- Author
-
Jordan Steinberg, Sabina Hajiyeva, Iskender Sinan Genco, Wojciech Dec, Bugra Tugertimur, and Beatriz Caraballo Bordon
- Subjects
0301 basic medicine ,Adult ,medicine.medical_specialty ,Histology ,Adolescent ,Incidental cancer ,Mammaplasty ,Reduction Mammoplasty ,Pathology and Forensic Medicine ,03 medical and health sciences ,Breast Diseases ,Young Adult ,0302 clinical medicine ,Breast cancer ,medicine ,Humans ,In patient ,Aged ,Aged, 80 and over ,Incidental Findings ,Invasive carcinoma ,business.industry ,Cancer ,General Medicine ,Middle Aged ,medicine.disease ,030104 developmental biology ,Tissue sections ,030220 oncology & carcinogenesis ,Female ,Radiology ,business - Abstract
Reduction mammoplasty (RM) is one of the most common plastic surgeries in the United States. We aimed to demonstrate the rate of incidental atypical and malignant breast lesions (AMBL) found in RM specimens and the impact of the number of submitted tissue sections on the rate of AMBL.We analysed our database for patients who had undergone reduction mammoplasty between 2000 and 2018. Patients with a history of breast cancer were excluded from the study. All pathology reports were analysed for AMBL (ALH, LCIS, FEA, ADH, DCIS, invasive carcinoma). The grossing protocol was to submit 10 sections from each breast between 2000 and 2013 and six sections between 2014 and 2018. One hundred and sixty-nine of 5208 patients (3.3%) and 216 of 10 340 RM specimens (2.1%) showed at least one AMBL. Nineteen (0.36%) patients had incidental cancer. The median age of patients with AMBL was significantly higher than patients without ABL (aged 59 years versus 45 years). There was no cancer in patients aged30 years. The age-controlled rate of overall AMBL as well as atypia and cancer only did not decrease by submitting fewer sections during the 2014-18 period compared to the 2010-13 period.Decreasing the number of tissue sections from 10 to six did not lead to a significant decrease in the rate of overall AMBL or cancer. Our data suggest that submitting six tissue sections from each breast for patients aged30 years and two sections from each breast for patients aged30 years would be sufficient.
- Published
- 2020